Patient Selection and Informed Consent

Michael Conlin, Nicholas Tadros

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Abstract

    Patients with upper urinary tract transitional cell carcinoma are usually best treated with nephroureterectomy. However, when possible, a nephron-sparing approach is desirable. Ureteroscopy has been successfully used for these patients, but at times this will not be possible due to anatomy or tumor volume. This chapter will review the indications for endoscopic management of upper tract transitional cell carcinoma, and when a percutaneous approach might be indicated. There are many competing factors that must be weighed when counseling our patients. We will also review the risks that are unique to the percutaneous approach.

    Original languageEnglish (US)
    Title of host publicationPercutaneous Renal Surgery
    Publisherwiley
    Pages190-195
    Number of pages6
    ISBN (Electronic)9781118670903
    ISBN (Print)9781118278734
    DOIs
    StatePublished - Oct 28 2013

    Fingerprint

    Informed Consent
    Patient Selection
    Transitional Cell Carcinoma
    Ureteroscopy
    Nephrons
    Tumor Burden
    Urinary Tract
    Counseling
    Anatomy

    Keywords

    • Complications
    • Endoscopy
    • Percutaneous
    • Transitional cell carcinoma
    • Treatment

    ASJC Scopus subject areas

    • Medicine(all)

    Cite this

    Conlin, M., & Tadros, N. (2013). Patient Selection and Informed Consent. In Percutaneous Renal Surgery (pp. 190-195). wiley. https://doi.org/10.1002/9781118670903.ch20

    Patient Selection and Informed Consent. / Conlin, Michael; Tadros, Nicholas.

    Percutaneous Renal Surgery. wiley, 2013. p. 190-195.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Conlin, M & Tadros, N 2013, Patient Selection and Informed Consent. in Percutaneous Renal Surgery. wiley, pp. 190-195. https://doi.org/10.1002/9781118670903.ch20
    Conlin M, Tadros N. Patient Selection and Informed Consent. In Percutaneous Renal Surgery. wiley. 2013. p. 190-195 https://doi.org/10.1002/9781118670903.ch20
    Conlin, Michael ; Tadros, Nicholas. / Patient Selection and Informed Consent. Percutaneous Renal Surgery. wiley, 2013. pp. 190-195
    @inbook{0acb6a12044544edbd1f703633126433,
    title = "Patient Selection and Informed Consent",
    abstract = "Patients with upper urinary tract transitional cell carcinoma are usually best treated with nephroureterectomy. However, when possible, a nephron-sparing approach is desirable. Ureteroscopy has been successfully used for these patients, but at times this will not be possible due to anatomy or tumor volume. This chapter will review the indications for endoscopic management of upper tract transitional cell carcinoma, and when a percutaneous approach might be indicated. There are many competing factors that must be weighed when counseling our patients. We will also review the risks that are unique to the percutaneous approach.",
    keywords = "Complications, Endoscopy, Percutaneous, Transitional cell carcinoma, Treatment",
    author = "Michael Conlin and Nicholas Tadros",
    year = "2013",
    month = "10",
    day = "28",
    doi = "10.1002/9781118670903.ch20",
    language = "English (US)",
    isbn = "9781118278734",
    pages = "190--195",
    booktitle = "Percutaneous Renal Surgery",
    publisher = "wiley",

    }

    TY - CHAP

    T1 - Patient Selection and Informed Consent

    AU - Conlin, Michael

    AU - Tadros, Nicholas

    PY - 2013/10/28

    Y1 - 2013/10/28

    N2 - Patients with upper urinary tract transitional cell carcinoma are usually best treated with nephroureterectomy. However, when possible, a nephron-sparing approach is desirable. Ureteroscopy has been successfully used for these patients, but at times this will not be possible due to anatomy or tumor volume. This chapter will review the indications for endoscopic management of upper tract transitional cell carcinoma, and when a percutaneous approach might be indicated. There are many competing factors that must be weighed when counseling our patients. We will also review the risks that are unique to the percutaneous approach.

    AB - Patients with upper urinary tract transitional cell carcinoma are usually best treated with nephroureterectomy. However, when possible, a nephron-sparing approach is desirable. Ureteroscopy has been successfully used for these patients, but at times this will not be possible due to anatomy or tumor volume. This chapter will review the indications for endoscopic management of upper tract transitional cell carcinoma, and when a percutaneous approach might be indicated. There are many competing factors that must be weighed when counseling our patients. We will also review the risks that are unique to the percutaneous approach.

    KW - Complications

    KW - Endoscopy

    KW - Percutaneous

    KW - Transitional cell carcinoma

    KW - Treatment

    UR - http://www.scopus.com/inward/record.url?scp=85027220593&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85027220593&partnerID=8YFLogxK

    U2 - 10.1002/9781118670903.ch20

    DO - 10.1002/9781118670903.ch20

    M3 - Chapter

    AN - SCOPUS:85027220593

    SN - 9781118278734

    SP - 190

    EP - 195

    BT - Percutaneous Renal Surgery

    PB - wiley

    ER -